The Biopharmaceutical Excipients Market Size was valued at USD 2.37 billion in 2022, and is expected to reach USD 3.96 billion by 2030 and grow at a CAGR of 6.6% over the forecast period 2023-2030. Several key factors are propelling this market growth: Soaring demand for biologics: The rise of complex biopharmaceuticals like antibodies and gene therapies, with unique...

The Epilepsy Device Market Size was valued at USD 1.52 billion in 2022 and is expected to reach USD 2.96 billion by 2030 and grow at a CAGR of 8.7% over the forecast period 2023-2030. Several key factors are propelling this market growth: Rising epilepsy prevalence: Increasing awareness and improved diagnostics lead to more accurate diagnoses, revealing a larger population...

The multiple sclerosis treatment market is witnessing significant growth, driven by the increasing availability and efficacy of multiple sclerosis medications. Multiple sclerosis (MS) medications encompass a diverse range of drugs aimed at managing the symptoms and slowing the progression of this chronic autoimmune disorder affecting the central nervous system. These medications include...

The Host Cell Protein (HCP) testing market has been steadily growing, driven by advancements in biopharmaceutical manufacturing and the increasing demand for effective quality control measures. According to recent market research, the HCP testing market size was valued at USD 1.26 billion in 2022 and is projected to reach USD 1.99 billion by 2030, with a compound annual growth rate (CAGR) of...

The mRNA Therapeutics Market size was valued at USD 39.40 billion in 2022 and is expected to grow at USD 45.40 billion by 2030 and grow at a CAGR of 1.5% over the forecast period of 2023-2030. Several key factors are propelling this unprecedented market expansion: Breakthroughs in mRNA technology and delivery systems: Advancements in delivery mechanisms and targeting strategies...

The Toxoid Vaccine Market size was worth US$ 5.61 billion in 2022 and is estimated to reach US$ 8.22 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2023-2030. Several key factors are propelling this market growth: Rising Immunization Rates: Increased emphasis on global vaccination programs, particularly in developing countries, drives demand for...